It has begun: Foxconn amassing army of workers for iPhone 18 Pro assembly
appleinsider - Months ahead of the fall launches, and historically right on time, Apple supply chain partner Foxconn has started to hire a small army of assemblers to build the iPhone 18 Pro.Workers at a Foxconn facility - Image source: FoxconnEach summer, the Apple sup…
AI Summary: Agenus has suspended the BATTMAN clinical trial and announced a follow‑on program called ROBBIN after strategic reassessment, a move that has raised questions about transparency and participant communication. The abrupt pivot highlights tensions between rapid corporate decision‑making and the need to maintain patient trust in oncology research.
The AACR Rare Cancers Initiative: Uniting Researchers, Undoing Barriers, and Unleashing Progress
Steve Schneible / aacr - At the recent AACR Special Conference on Breaking Barriers in the Fight Against Rare Cancers, AACR Immediate Past President Lillian L. Siu, MD, FAACR, announced the AACR Rare Cancers Initiative. Learn more about how this new Initiative will marshal global…
AI Summary: The AACR has unveiled a Rare Cancers Initiative to coordinate researchers, streamline data sharing, and speed therapeutic development for uncommon tumor types. By pooling expertise, funding and networks, the program seeks to overcome the chronic scarcity of trials and resources that leave rare‑cancer patients waiting for attention that’s been hard to come by.
AHRQ terminates dozens of patient care research grants: Report
Elizabeth Gregerson / beckershospitalreview - HHS’ Agency for Healthcare Research and Quality has begun to terminate funding for research related to strengthening patient safety, care delivery, clinical practice and policy, and workforce training, according to a July 16 report from AcademyHealth. Aca…
AI Summary: The Agency for Healthcare Research and Quality has discontinued dozens of active research awards focused on patient care, citing programmatic changes and funding shifts. The abrupt terminations leave investigators scrambling and could slow progress on projects aimed at improving clinical practice and outcomes—proof that research pipelines are only as sturdy as their funding lines.
Could this enzyme help remove 'zombie' cells from our tissues?
medicalxpress - Our population is aging. The United Nations reports that by 2050, the number of people age 85 and older on our planet is set to triple. But a longer life span isn't the same as a longer health span (the number of years we spend healthy). Salk Institute sc…
AI Summary: Researchers identified an enzyme that selectively targets senescent “zombie” cells, restoring tissue function in preclinical models and hinting at anti‑aging and therapeutic possibilities. The findings generated excitement for potential disease‑modifying strategies, but experts caution that translating enzyme‑based fixes from mice to humans will require careful safety studies and sober expectations.
US actions harm global efforts to prevent and treat HIV in dozens of countries, new report says
medicalxpress - The Trump administration's disruptions to a global AIDS relief program have forced organizations to close clinics, lay off staff and cut services, seriously impeding efforts to prevent and treat the disease in dozens of countries, a new report released Tu…
AI Summary: A new analysis concludes recent U.S. policy shifts have weakened international HIV prevention and treatment initiatives, disrupting funding flows and partnership stability. Public health experts caution the changes could reverse progress in vulnerable regions, urging policymakers to recalibrate support to sustain global gains against HIV/AIDS.